Clinical Trial Update: Safety and Dose Finding Study of New Vehicle Formulations Containing Ingenol Mebutate to Treat Actinic Keratosis on the Forearm [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 safety and dose-finding trial evaluating new vehicle formulations containing Ingenol Mebutate for actinic keratosis on the forearm, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Ingenol Mebutate (ingenol mebutate)

Snippet

Sponsor: LEO Pharma | Conditions: Actinic Keratosis | Phase 1, Phase 2 | Status: COMPLETED